Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) FCF Margin (2016 - 2025)

Historic FCF Margin for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to 189.86%.

  • Regenxbio's FCF Margin fell 209300.0% to 189.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 65.88%, marking a year-over-year increase of 1532000.0%. This contributed to the annual value of 210.69% for FY2024, which is 423700.0% up from last year.
  • As of Q3 2025, Regenxbio's FCF Margin stood at 189.86%, which was down 209300.0% from 232.84% recorded in Q2 2025.
  • Regenxbio's 5-year FCF Margin high stood at 82.0% for Q4 2021, and its period low was 447.99% during Q1 2023.
  • For the 5-year period, Regenxbio's FCF Margin averaged around 209.22%, with its median value being 206.19% (2024).
  • Its FCF Margin has fluctuated over the past 5 years, first plummeted by -2250600bps in 2022, then surged by 3951800bps in 2025.
  • Regenxbio's FCF Margin (Quarter) stood at 82.0% in 2021, then crashed by -274bps to 143.06% in 2022, then plummeted by -32bps to 188.57% in 2023, then grew by 18bps to 154.16% in 2024, then decreased by -23bps to 189.86% in 2025.
  • Its FCF Margin stands at 189.86% for Q3 2025, versus 232.84% for Q2 2025 and 36.63% for Q1 2025.